Χώρα: Αρμενία
Γλώσσα: Αγγλικά
Πηγή: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
meropenem
Hankook Korus Pharm Co.
J01DH02
meropenem
500mg
powder for solution for i/v injection/infusion
(1), (5), (10) glass vials
Prescription
Registered
2015-12-17
Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT Meropenem-Asteria Inj. 500mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient No. Chemical Name Quantity/vial Use 1 Meropenem Dried Sodium Carbonate 604mg (500mg as Meropenem) Active ingredient 3. PHARMACEUTICAL FORM Power for Injection 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Strains Staphylococcus aureus , Streptococcus pyogenes, Streptococcus agalactiae, streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, Peptostreptococcus species , Klebsiella pneumoniae, B. thetaiotaomicron, and Peptostreptococcus species . Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. Indication Pneumonia including community acquired pneumonia and nosocomial pneumonia, Broncho pulmonary infections in cystic fibrosis, Complicated urinary tract infections, Complicated intra-abdominal infections, Intra- and post-partum infections, Complicated skin and soft tissue infections, Acute bacterial meningitis (Pediatric patients ≥ 3 months only) 4.2 Posology and method of administration Adults and Children over 50 kg body weight The recommended dose of Meropenem for Injection is 500 mg given every 8 hours for skin and skin structure infections. Meropenem for Injection should be administered by intravenous infusion over approximately 15 to 30 minutes. Adults with Renal Impairment Dosage should be reduced in patients with creatinine clearance less than 51 mL/min. Summary of Product Characteristics Creatinine Clearance(mL/min) Dose Dosing Inteval ≥ 51 Recommended dose Every 8h 26-50 Recommended dose Every 12h 10-25 One-half recommended dose Every 12h < 10 One-half recommended dose Every 24h Elderly Patients No dosage adjustment is required for elderly patients with creatinine clearance values above 50 mL/min. Pediatric Patients Children under 3 months of age The safety and efficacy of Meropenem in children under 3 months Διαβάστε το πλήρες έγγραφο